Holloway Kathleen Anne, Kotwani Anita, Batmanabane Gitanjali, Santoso Budiono, Ratanawijitrasin Sauwakon, Henry David
International Institute of Health Management Research, Jaipur, India.
Institute of Development Studies, University of Sussex, Brighton, BN1 9RE, UK.
BMC Health Serv Res. 2018 Jul 5;18(1):526. doi: 10.1186/s12913-018-3333-1.
Irrational use of medicines is widespread in the South-East Asia Region (SEAR), where policy implementation to encourage quality use of medicines (QUM) is often low. The aim was to determine whether public-sector QUM is better in SEAR countries implementing essential medicines (EM) policies than in those not implementing them.
Data on six QUM indicators and 25 EM policies were extracted from situational analysis reports of 20 country (2-week) visits made during 2010-2015. The average difference (as percent) for the QUM indicators between countries implementing versus not implementing specific policies was calculated. Policies associated with better (> 1%) QUM were included in regression of a composite QUM score versus total number of policies implemented.
Twenty-two policies were associated with better (> 1%) QUM. Twelve policies were associated with 3.6-9.5% significantly better use (p < 0.05), namely: standard treatment guidelines; formulary; a government unit to promote QUM; continuing health worker education on prescribing by government; limiting over-the-counter (OTC) availability of systemic antibiotics; disallowing public-sector prescriber revenue from medicines sales; not charging fees at the point of care; monitoring advertisements of OTC medicines; public education on QUM; and a good drug supply system. There was significant correlation between the number of policies implemented out of 22 and the composite QUM score (r = 0.71, r = 0.50, p < 0.05).
Country situational analyses allowed rapid data collection that showed EM policies are associated with better QUM. SEAR countries should implement all such policies.
药品不合理使用在东南亚地区(SEAR)广泛存在,该地区鼓励合理用药(QUM)的政策实施情况往往较差。目的是确定在东南亚地区实施基本药物(EM)政策的国家,其公共部门的合理用药情况是否优于未实施这些政策的国家。
从2010 - 2015年期间对20个国家(为期2周)的访问情况分析报告中提取了关于6个合理用药指标和25项基本药物政策的数据。计算了实施特定政策与未实施特定政策的国家在合理用药指标上的平均差异(以百分比表示)。与更好的(>1%)合理用药相关的政策被纳入综合合理用药得分与实施政策总数的回归分析。
22项政策与更好的(>1%)合理用药相关。12项政策与显著更好(3.6 - 9.5%)的用药情况相关(p < 0.05),即:标准治疗指南;药品处方集;一个促进合理用药的政府单位;政府开展的关于处方开具的卫生工作者继续教育;限制全身性抗生素的非处方(OTC)供应;禁止公共部门开处方者从药品销售中获取收入;在医疗点不收费;监测非处方药品广告;开展合理用药公众教育;以及良好的药品供应系统。在22项实施的政策数量与综合合理用药得分之间存在显著相关性(r = 0.71,r = 0.50,p < 0.05)。
国家情况分析允许快速收集数据,结果表明基本药物政策与更好的合理用药相关。东南亚地区国家应实施所有此类政策。